This may be explained by observations that APOL1 high-risk genotypes are more potent drivers of kidney disease (especially ESKD) in people with HIV compared with those without HIV,8,9 thus partially obscuring the effect of SCT. The gene discussed is APOL1; the disease is kidney disorder.